PD61-11 A PHASE II STUDY OF 6-MONTHS APALUTAMIDE PRIOR TO RADICAL PROSTATECTOMY IN INTERMEDIATE RISK PATIENTS TO REDUCE THE FREQUENCY OF PATHOLOGIC FEATURES THAT DRIVE POST-OPERATIVE RADIATION THERAPY

You have accessJournal of UrologyProstate Cancer: Localized: Surgical Therapy V (PD61)1 Sep 2021PD61-11 A PHASE II STUDY OF 6-MONTHS APALUTAMIDE PRIOR TO RADICAL PROSTATECTOMY IN INTERMEDIATE RISK PATIENTS TO REDUCE THE FREQUENCY OF PATHOLOGIC FEATURES THAT DRIVE POST-OPERATIVE RADIATION THERAPY John Davis, Brian Chapin, Curtis Pettaway, Lisly Chery, Louis Pisters, John Ward, John Papadopoulos, Ashish Kamat, Marisa Lozano, Patricia Troncoso, and...